{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:45:23Z","timestamp":1782960323046,"version":"3.54.5"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Medizinische Hochschule Brandenburg CAMPUS GmbH"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Autoimmune connective tissue diseases (ACTD), including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sj\u00f6gren\u2019s disease (SD), and idiopathic inflammatory myopathies (IIM), are associated with markedly increased cardiovascular risk (CVR) that is insufficiently captured by conventional risk scores. Reliable biomarkers for CVR stratification in ACTD are lacking. This exploratory, hypothesis-generatig study aimed to investigate whether metabolomic alterations reflect CVR across ACTD subtypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this cross-sectional, exploratory study, patients with SLE (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200933), SSc (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200918), SD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200916), and IIM (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20099) were recruited from a tertiary rheumatology center. Serum metabolomic profiling was performed using \u00b9H-NMR spectroscopy. Associations between 113 quantified metabolites and clinical CVR parameters (including age, sex, body mass index, glucocorticoid use, Framingham score, hypertension, diabetes, lipid parameters, and lifestyle factors) were analyzed using non-parametric statistics with false discovery rate correction. Correlation analyses were conducted using Spearman coefficients.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Metabolomic alterations varied substantially across ACTD subtypes and CVR factors. Lipid metabolites showed the strongest and most consistent associations with CVR parameters. The Framingham score correlated with 11 metabolites in SLE, 1 in SSc, 2 in SD, and 93 in IIM, predominantly involving lipid components. Diabetes mellitus was associated with extensive metabolomic changes, particularly in SSc (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200962 metabolites), followed by SD (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200920) and SLE (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20095). In contrast, arterial hypertension showed minimal metabolomic differentiation across most ACTD, except in IIM. Body mass index correlated mainly with lipid metabolites in SSc, but not in SLE. Glucocorticoid therapy and dosage were strongly associated with alterations in lipid metabolism, especially in SLE and SSc. Across all entities, correlations with total cholesterol, LDL, and HDL were dominated by lipid metabolites. Associations with renal markers (UACR) were limited.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>ACTD are characterized by heterogeneous metabolomic signatures associated with cardiovascular risk factors. Larger, longitudinal studies are required to validate these findings and to determine their clinical utility in cardiovascular risk stratification in ACTD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s41927-026-00670-8","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:48:57Z","timestamp":1782902937000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomics and cardiovascular risk factors in autoimmune-mediated connective tissue diseases \u2013 an exploratory, hypothesis-generating study"],"prefix":"10.1186","volume":"10","author":[{"given":"Emily","family":"Deichsler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Heelemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina","family":"Strathmeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meike","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Dammermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Ritter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Patschan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"10055","key":"670_CR1","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet Lond Engl. 2016;388(10055):2023\u201338. https:\/\/doi.org\/10.1016\/S0140-6736(. 16)30173-8 PubMed PMID: 27156434.","journal-title":"Lancet Lond Engl"},{"issue":"6","key":"670_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1002\/acr.21621","volume":"64","author":"JD Reveille","year":"2012","unstructured":"Reveille JD, Witter JP, Weisman MH. Prevalence of axial spondylarthritis in the United States: Estimates from a cross-sectional survey. Arthritis Care Res. 2012;64(6):905\u201310. https:\/\/doi.org\/10.1002\/acr.21621.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"670_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1136\/annrheumdis-2016-209775","volume":"76","author":"R Agca","year":"2017","unstructured":"Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJL, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015\/2016 update. Ann Rheum Dis. 2017;76(1):17\u201328. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209775. PubMed PMID: 27697765.","journal-title":"Ann Rheum Dis"},{"issue":"38","key":"670_CR4","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"McEvoy JW, McCarthy CP, Bruno RM, Brouwers S, Canavan MD, Ceconi C, et al. 2024 ESC Guidelines for the management of elevated blood pressure and hypertension. Eur Heart J. 2024;45(38):3912\u20134018. https:\/\/doi.org\/10.1093\/eurheartj\/ehae178. PubMed PMID: 39210715.","journal-title":"Eur Heart J"},{"issue":"12","key":"670_CR5","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.3390\/diagnostics11122363","volume":"11","author":"I Ferraz-Amaro","year":"2021","unstructured":"Ferraz-Amaro I, Corrales A, Atienza-Mateo B, Vegas-Revenga N, Prieto-Pe\u00f1a D, S\u00e1nchez-Mart\u00edn J, et al. SCORE2 Assessment in the Calculation of Cardiovascular Risk in Patients with Rheumatoid Arthritis. Diagn Basel Switz. 2021;11(12):2363. https:\/\/doi.org\/10.3390\/diagnostics11122363. PubMed PMID: 34943599; PubMed Central PMCID: PMC8700102.","journal-title":"Diagn Basel Switz"},{"issue":"5","key":"670_CR6","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1007\/s00059-013-3881-4","volume":"39","author":"MR Sayin","year":"2014","unstructured":"Sayin MR, Cetiner MA, Karabag T, Akpinar I, Sayin E, Kurcer MA, et al. Framingham risk score and severity of coronary artery disease. Herz. 2014;39(5):638\u201343. https:\/\/doi.org\/10.1007\/s00059-013-3881-4. PubMed PMID: 23873009.","journal-title":"Herz"},{"issue":"4","key":"670_CR7","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1024\/0301-1526\/a000057","volume":"39","author":"H Uthoff","year":"2010","unstructured":"Uthoff H, Staub D, Socrates T, Meyerhans A, Bundi B, Schmid HP, et al. PROCAM-, FRAMINGHAM-, SCORE- and SMART-risk score for predicting cardiovascular morbidity and mortality in patients with overt atherosclerosis. VASA Z Gefasskrankheiten. 2010;39(4):325\u201333. https:\/\/doi.org\/10.1024\/0301-1526\/a000057. PubMed PMID: 21104622.","journal-title":"VASA Z Gefasskrankheiten"},{"issue":"3","key":"670_CR8","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.amjcard.2012.03.044","volume":"110","author":"CS Crowson","year":"2012","unstructured":"Crowson CS, Matteson EL, Roger VL, Therneau TM, Gabriel SE. Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis. Am J Cardiol. 2012;110(3):420\u20134. https:\/\/doi.org\/10.1016\/j.amjcard.2012.03.044. PubMed PMID: 22521305; PubMed Central PMCID: PMC3398213.","journal-title":"Am J Cardiol"},{"key":"670_CR9","doi-asserted-by":"publisher","first-page":"152694","DOI":"10.1016\/j.semarthrit.2025.152694","volume":"72","author":"J Llorca","year":"2025","unstructured":"Llorca J, Ferraz-Amaro I, Casta\u00f1eda S, Raya E, Rodr\u00edguez-Rodr\u00edguez L, Rodr\u00edguez-Montero S, et al. Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases. Semin Arthritis Rheum. 2025;72:152694. https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152694.","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"670_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mas.20108","volume":"26","author":"K Dettmer","year":"2007","unstructured":"Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics. Mass Spectrom Rev. 2007;26(1):51\u201378. 10. 1002\/mas.20108 PubMed PMID: 16921475; PubMed Central PMCID: PMC1904337.","journal-title":"Mass Spectrom Rev"},{"issue":"2","key":"670_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.14740\/jocmr6145","volume":"17","author":"I Claus","year":"2025","unstructured":"Claus I, Hoffmeister M, Strathmeyer S, Heelemann S, Remus C, Dammermann W, et al. Metabolomics for Distinguishing Cardiovascular Risk in Rheumatoid Arthritis Across Different Disease-Modifying Antirheumatic Drug Therapies. J Clin Med Res. 2025;17(2):89\u201396. https:\/\/doi.org\/10.14740\/jocmr6145. PubMed PMID: 39981338; PubMed Central PMCID: PMC11835553.","journal-title":"J Clin Med Res"},{"issue":"1","key":"670_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s41927-025-00546-3","volume":"9","author":"S Patschan","year":"2025","unstructured":"Patschan S, Remus C, Claus I, Hoffmeister M, Ritter O, Patschan D. Metabolomics in spondylarthritis. BMC Rheumatol. 2025;9(1):92. https:\/\/doi.org\/10.1186\/s41927-025-00546-3. PubMed PMID: 40702561; PubMed Central PMCID: PMC12285033.","journal-title":"BMC Rheumatol"},{"issue":"9","key":"670_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","volume":"78","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214819. PubMed PMID: 31383717.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"670_CR14","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737\u201347. https:\/\/doi.org\/10.1002\/art.38098. PubMed PMID: 24122180; PubMed Central PMCID: PMC3930146.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"670_CR15","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/acr.21591","volume":"64","author":"SC Shiboski","year":"2012","unstructured":"Shiboski SC, Shiboski CH, Criswell LA, Baer AN, Challacombe S, Lanfranchi H, et al. American College of Rheumatology classification criteria for Sj\u00f6gren\u2019s syndrome: a data-driven, expert consensus approach in the Sj\u00f6gren\u2019s International Collaborative Clinical Alliance cohort. Arthritis Care Res. 2012;64(4):475\u201387. https:\/\/doi.org\/10.1002\/acr.21591. PubMed PMID: 22563590; PubMed Central PMCID: PMC3349440.","journal-title":"Arthritis Care Res"},{"key":"670_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211468","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, et al. 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis. 2017;76(12):1955-1964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468.\u00a0PubMed PMID: 29079590; PubMed Central PMCID: PMC5736307."},{"issue":"25","key":"670_CR17","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group and ESC Cardiovascular risk collaboration","year":"2021","unstructured":"SCORE2 working group and ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42(25):2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309. PubMed PMID: 34120177; PubMed Central PMCID: PMC8248998.","journal-title":"Eur Heart J"},{"issue":"12","key":"670_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11886-020","volume":"22","author":"JA Regan","year":"2020","unstructured":"Regan JA, Shah SH. Obesity Genomics and Metabolomics: a Nexus of Cardiometabolic Risk. Curr Cardiol Rep. 2020;22(12):174. https:\/\/doi.org\/10.1007\/s11886-020-01422-x. PubMed PMID: 33040225; PubMed Central PMCID: PMC8133795.","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"670_CR19","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF, et al. A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance. Cell Metab. 2009;9(4):311\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2009.02.002.","journal-title":"Cell Metab"},{"issue":"10","key":"670_CR20","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1194\/jlr.P035808","volume":"54","author":"JM Weir","year":"2013","unstructured":"Weir JM, Wong G, Barlow CK, Greeve MA, Kowalczyk A, Almasy L, et al. Plasma lipid profiling in a large population-based cohort. J Lipid Res. 2013;54(10):2898\u2013908. https:\/\/doi.org\/10.1194\/jlr.P035808.","journal-title":"J Lipid Res"},{"issue":"12","key":"670_CR21","doi-asserted-by":"publisher","first-page":"e028022","DOI":"10.1161\/JAHA.122.028022","volume":"12","author":"Y Li","year":"2023","unstructured":"Li Y, Gray A, Xue L, Farb MG, Ayalon N, Andersson C, et al. Metabolomic Profiles, Ideal Cardiovascular Health, and Risk of Heart Failure and Atrial Fibrillation: Insights From the Framingham Heart Study. J Am Heart Assoc. 2023;12(12):e028022. https:\/\/doi.org\/10.1161\/JAHA.122.028022. PubMed PMID: 37301766; PubMed Central PMCID: PMC10356055.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"670_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/09612033221147471","volume":"32","author":"N Bello","year":"2023","unstructured":"Bello N, Meyers KJ, Workman J, Hartley L, McMahon M. Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis. Lupus. 2023;32(3):325\u201341. https:\/\/doi.org\/10.3390\/biology14040403.\u00a0PubMed PMID: 36547368; PubMed Central PMCID: PMC10012401.","journal-title":"Lupus"},{"issue":"7","key":"670_CR23","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1093\/rheumatology\/keab851","volume":"61","author":"A Xiong","year":"2022","unstructured":"Xiong A, Hu Z, Zhou S, Qiang Y, Song Z, Chen H, et al. Cardiovascular events in adult polymyositis and dermatomyositis: a meta-analysis of observational studies. Rheumatol Oxf Engl. 2022;61(7):2728\u201339. https:\/\/doi.org\/10.1093\/rheumatology\/keab851. PubMed PMID: 34791063.","journal-title":"Rheumatol Oxf Engl"},{"issue":"11\u201312","key":"670_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1002\/ansa.202000171","volume":"2","author":"A Guleria","year":"2021","unstructured":"Guleria A, Kumar U, Kumar D, Anuja RN, Singh AK. NMR-based serum and muscle metabolomics for diagnosis and activity assessment in idiopathic inflammatory myopathies. Anal Sci Adv. 2021;2(11\u201312):515\u201326. https:\/\/doi.org\/10.1002\/ansa.202000171. PubMed PMID: 38715864; PubMed Central PMCID: PMC10989623.","journal-title":"Anal Sci Adv"},{"issue":"4","key":"670_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/biology14040403","volume":"14","author":"ICR Gra\u00e7a","year":"2025","unstructured":"Gra\u00e7a ICR, Martins C, Ribeiro F, Nunes A. Understanding Hypertension: A Metabolomic Perspective. Biology. 2025;14(4):403. https:\/\/doi.org\/10.3390\/biology14040403.","journal-title":"Biology"},{"issue":"1","key":"670_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s11033-023-09107-8","volume":"51","author":"A Alqudah","year":"2024","unstructured":"Alqudah A, Qnais E, Wedyan M, Awali A, Bseiso Y, Gammoh O. Amino acid profiles: exploring their diagnostic and pathophysiological significance in hypertension. Mol Biol Rep. 2024;51(1):200. https:\/\/doi.org\/10.1007\/s11033-023-09107-8.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"670_CR27","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s11306-024-02182-3","volume":"20","author":"K Sekaran","year":"2024","unstructured":"Sekaran K, Zayed H. Identification of novel hypertension biomarkers using explainable AI and metabolomics. Metabolomics Off J Metabolomic Soc. 2024;20(6):124. https:\/\/doi.org\/10.1007\/s11306-024-02182-3. PubMed PMID: 39489869; PubMed Central PMCID: PMC11532322.","journal-title":"Metabolomics Off J Metabolomic Soc"},{"key":"670_CR28","doi-asserted-by":"publisher","unstructured":"Arjmand B, Dehghanbanadaki H, Yoosefi M, Rezaei N, Mohammadi Fateh S, Ghodssi-Ghassemabadi R, et al. Association of plasma acylcarnitines and amino acids with hypertension: a nationwide metabolomics study. PLoS One. 2023;18(1):e0279835. https:\/\/doi.org\/10.1371\/journal.pone.0279835.","DOI":"10.1371\/journal.pone.0279835"},{"issue":"1","key":"670_CR29","doi-asserted-by":"publisher","first-page":"6436","DOI":"10.1038\/s41598-020-63475-w","volume":"10","author":"L Calder\u00f3n-P\u00e9rez","year":"2020","unstructured":"Calder\u00f3n-P\u00e9rez L, Gosalbes MJ, Yuste S, Valls RM, Pedret A, Llaurad\u00f3 E, et al. Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study. Sci Rep. 2020;10(1):6436. https:\/\/doi.org\/10.1038\/s41598-020-63475-w.","journal-title":"Sci Rep"},{"key":"670_CR30","doi-asserted-by":"publisher","first-page":"6003102","DOI":"10.1155\/2023\/6003102","volume":"2023","author":"Y Liu","year":"2023","unstructured":"Liu Y, Dong G, Huang K, Hong Y, Chen X, Zhu M, et al. Metabolomics and Lipidomics Studies in Pediatric Type 1 Diabetes: Biomarker Discovery for the Early Diagnosis and Prognosis. Pediatr Diabetes. 2023;2023:6003102. https:\/\/doi.org\/10.1155\/2023\/6003102. PubMed PMID: 40303249; PubMed Central PMCID: PMC12016713.","journal-title":"Pediatr Diabetes"},{"issue":"2","key":"670_CR31","doi-asserted-by":"publisher","first-page":"107734","DOI":"10.1016\/j.jdiacomp.2020.107734","volume":"35","author":"N Mandal","year":"2021","unstructured":"Mandal N, Grambergs R, Mondal K, Basu SK, Tahia F, Dagogo-Jack S. Role of ceramides in the pathogenesis of diabetes mellitus and its complications. J Diabetes Complications. 2021;35(2):107734. https:\/\/doi.org\/10.1016\/j.jdiacomp.2020.107734. PubMed PMID: 33268241; PubMed Central PMCID: PMC8663915.","journal-title":"J Diabetes Complications"},{"issue":"11","key":"670_CR32","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1507\/endocrj.EJ","volume":"67","author":"XH Wang","year":"2020","unstructured":"Wang XH, Xu F, Cheng M, Wang X, Zhang DM, Zhao LH, et al. Fasting serum total bile acid levels are associated with insulin sensitivity, islet \u03b2-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes. Endocr J. 2020;67(11):1107\u201317. https:\/\/doi.org\/10.1507\/endocrj.EJ. 20-0201 PubMed PMID: 32684527.","journal-title":"Endocr J"},{"issue":"7","key":"670_CR33","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/biom13071086","volume":"13","author":"L Balint","year":"2023","unstructured":"Balint L, Socaciu C, Socaciu AI, Vlad A, Gadalean F, Bob F, et al. Quantitative, Targeted Analysis of Gut Microbiota Derived Metabolites Provides Novel Biomarkers of Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus Patients. Biomolecules. 2023;13(7):1086. https:\/\/doi.org\/10.3390\/biom13071086. PubMed PMID: 37509122; PubMed Central PMCID: PMC10377254.","journal-title":"Biomolecules"},{"issue":"1","key":"670_CR34","doi-asserted-by":"publisher","first-page":"6445","DOI":"10.1038\/s41598-024-57275-9","volume":"14","author":"IW Chen","year":"2024","unstructured":"Chen IW, Wang WT, Lai YC, Lin CM, Liu PH, Wu SZ, et al. Association between systemic sclerosis and risk of cerebrovascular and cardiovascular disease: a meta-analysis. Sci Rep. 2024;14(1):6445. https:\/\/doi.org\/10.1038\/s41598-024-57275-9. PubMed PMID: 38499699; PubMed Central PMCID: PMC10948904.","journal-title":"Sci Rep"},{"issue":"6","key":"670_CR35","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.berh.2011.11.002","volume":"25","author":"CM Spies","year":"2011","unstructured":"Spies CM, Strehl C, van der Goes MC, Bijlsma JWJ, Buttgereit F, Glucocorticoids. Best Pract Res Clin Rheumatol. 2011;25(6):891\u2013900. PubMed PMID: 22265268.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"4","key":"670_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.23876\/j.krcp.22.152","volume":"42","author":"S Kwon","year":"2023","unstructured":"Kwon S, Hyeon JS, Jung Y, Li L, An JN, Kim YC, et al. Urine myo-inositol as a novel prognostic biomarker for diabetic kidney disease: a targeted metabolomics study using nuclear magnetic resonance. Kidney Res Clin Pract. 2023;42(4):445\u201359. https:\/\/doi.org\/10.23876\/j.krcp.22.152. PubMed PMID: 37551126; PubMed Central PMCID: PMC10407640.","journal-title":"Kidney Res Clin Pract"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00670-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00670-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:06:36Z","timestamp":1782957996000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00670-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00670-8","relation":{"references":[{"id-type":"doi","id":"10.1136\/annrheumdis-2017-211468","asserted-by":"subject"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Brandenburg Medical School Ethics Committee (E-01-20190911). All participants provided written informed consent by signing a consent form. The study was performed in accordance with the in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"54"}}